​EARLY STAGE TECHNOLOGY

MANAGEMENT CONSULTANCY

SINCE 2010

Welcome to Biospire, a global innovation and technology management consultancy.

We specialise in working with early stage technology projects including those developed within academic environments. We provides support and development services to a variety of clients including university technology transfer offices, research councils, large corporates, technology-based SMEs, and partnering work with other specialist consultancies.

Global Ecosystems | Open Innovation | Proactive Business Development | Technology Management

We partner with the world's leading innovative companies looking for international collaborations

Japan to Global

Why don't you explore your investment and business acquisition targets to high-end Japanese startup companies?

Biospire selects and supports best-in-class Japanese startup companies looking for global communications, collaborations, business development and investments. 

Biospire introduces integrated endorsement systems for those startups suitable to introduce to international stakeholders.

Endorsement of selected Japanese startup companies

Unlike decades ago, Japan is now recognised as a grate place to invest, however we know that it is difficult to select good ones. Biospire experienced consultant team endorses selected startup companies using our experiences and databases.

Please feel free to request us for further contact details.

Proactive global business development support

In life science field, 5-10 times bigger market is existing outside Japan, however, not many startups have clear global business strategy at the early stage.

Biospire's global business experts guide the best scenario to mange global marketing, partnering to the best investors and the supply chain management.

Global to Japan

Japan is a great place to explore your businesses.

Our business development experts fully understand its unique business culture to bridge you with the best business partners.

Biospire links to local ecosystems, government, distributors, business development specialists including sole-reps, and of course high value end-users. 

Proactive & strategic business entry support

We fully understand the uniqueness of the Japanese business culture system. This is not only for language and supply chain complication. Business is built with key decision-make, relationship development, trusting people based on the culture.

Biospire will be your business assist advisor to guide to build the best strategies to enter the Japanese market.

Primary contact for your business transaction in Japan

Contracts with distributors, end users and also for legal and financial payment is complicated to do businesses in Japan.

Biospire is a Japanese legal entity that works as your account to facilitate the business with accepting multiple currency.

Partnering and Investment Opportunities   

 

Japan to Global

Biospire endorses key life science startup companies from Japan looking for international collaborations.

  • M Bio Technology Inc.

    TRL: 

    5

    Established: 

    2005

    Tokyo, JP

    Location: 

    Patent value:

    Please ask

    Mycoplasma

    Glycolipid

    Antigen

    Vaccine

    Mycoplasma

    M Biotech has key patents for the structure of glycolipid on mycoplasma membrane surfaces as well as its synthesis methodology. These technologies could be applied both for high sensitive diagnoses and vaccine development with applying the glycolipid-antigen to produce its antibody. M Biotech encourages global business expansion with identifying the business and technical partners.

  • Surg storage Co., Ltd.

    TRL: 

    7

    Established: 

    2020

    Tokyo, JP

    Location: 

    Patent value:

    Please ask

    Endoscopic Surgery

    Big data

    AI assisted

    Robotics

    Surgical data

    Surge storage can now provide surgical videos and surgical-related data for commercial uses such as for the improvement of the quality of the medical devices. Spinout from National Cancer Hospital in Japan.

  • Cellusion Inc.

    TRL: 

    5

    Established: 

    2015

    Tokyo, JP

    Location: 

    Patent value:

    Please ask

    Cell therapy

    Ophthalmology

    Allogeneic

    iPSC

    Regenerative medicine

    Cellusion has own IP and technologies to develop and obtain iPS-derived corneal endothelial cells suitable for corneal transplantation to be able to treat thousands of patients from a single batch.

  • FOVE, Inc.

    TRL: 

    9

    Established: 

    2014

    Tokyo, JP

    Location: 

    Patent value:

    Please ask

    Eye Tracking

    Virtual Reality

    Glaucoma

    Dementia

    VR

    FOVE has unique eye tracking VR system and technologies, and now looking for healthcare application partners such as dementia (cognitive) research fields, e.g. self-check device development.

  • MiCAN Technologies

    TRL: 

    7

    Established: 

    2016

    Kyoto, JP

    Location: 

    Patent value:

    Please ask

    Human iPSC

    Myeloid linage cells

    Immature dendritic cells

    COVID-19

    Regenerative medicine

    MiCAN develops iPS-derived myeloid (immature dendritic cells) to be applied for virus research (including dengue and COVID-19) as well as for drug safety applications.

  • PuREC Co., Ltd.

    TRL: 

    6

    Established: 

    2016

    Shimane, JP

    Location: 

    Patent value:

    Please ask

    MSC

    stem cell therapy

    hypophosphatasia

    disc herination

    Regenerative medicine

    PuREC is a Shimane University spinout company having patented technologies to produce extremely purified MSC, or mesenchymal stem cells. PuREC's REC is coming from Rapidly Expanding Cells enabling to obtain 10^12 ordered pure cells within 12 weeks without requiring complicated methodologies including gene-modification. 

WHAT'S NEW

 

CONTACT US TODAY

 
CELLUSION

Go to link